title: Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy.
abstract: Although alpha-synuclein (alpha-syn) has been implicated as a major component of the abnormal filaments that form glial cytoplasmic inclusions (GCIs) in multiple system atrophy (MSA), it is uncertain if GCIs are homogenous and contain full-length alpha-syn. Since this has implications for hypotheses about the pathogenesis of GCIs, we used a novel panel of antibodies to defined regions throughout alpha-syn in immunohistochemical epitope mapping studies of GCIs in MSA brains. Although the immunostaining profile of GCIs with these antibodies was similar for all MSA brains, there were significant differences in the immunoreactivity of the alpha-syn epitopes detected in GCIs. Notably, carboxy-terminal alpha-syn epitopes were immunodominant in GCIs, but the entire panel of antibodies immunostained cortical Lewy bodies (LBs) in dementia with LBs brain with similar intensity. While the distribution of alpha-syn labeled GCIs paralleled that previously reported using silver stains, antibodies to carboxy-terminal alpha-syn epitopes revealed a previously undescribed burden of GCIs in the MSA hippocampal formation. Finally, Western blots demonstrated detergent insoluble monomeric and high-molecular weight alpha-syn species in GCI rich MSA cerebellar white matter. Collectively, these data indicate that alpha-syn is a prominent component of GCIs in MSA, and that GCIs and LBs may result from cell type specific conformational or post-translational permutations in alpha-syn.
authors.affiliation: Center for Neurodegenerative Disease Research, University of Pennsylvania School of Medicine, Philadelphia 19104, USA.
authors.forename: J E
authors.initials: JE
authors.lastname: Duda
authors.forename: B I
authors.initials: BI
authors.lastname: Giasson
authors.forename: T L
authors.initials: TL
authors.lastname: Gur
authors.forename: T J
authors.initials: TJ
authors.lastname: Montine
authors.forename: D
authors.initials: D
authors.lastname: Robertson
authors.forename: I
authors.initials: I
authors.lastname: Biaggioni
authors.forename: H I
authors.initials: HI
authors.lastname: Hurtig
authors.forename: M B
authors.initials: MB
authors.lastname: Stern
authors.forename: S M
authors.initials: SM
authors.lastname: Gollomp
authors.forename: M
authors.initials: M
authors.lastname: Grossman
authors.forename: V M
authors.initials: VM
authors.lastname: Lee
authors.forename: J Q
authors.initials: JQ
authors.lastname: Trojanowski
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000906:Antibodies; D000911:Antibodies, Monoclonal; D001479:Basal Ganglia / Q000473:pathology; D001921:Brain / Q000473:pathology*; D002531:Cerebellum / Q000473:pathology; D005260:Female; D006624:Hippocampus / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008526:Medulla Oblongata / Q000473:pathology; D008636:Mesencephalon / Q000473:pathology; D008875:Middle Aged; D019578:Multiple System Atrophy / Q000473:pathology*; D009419:Nerve Tissue Proteins / Q000032:analysis*; D011149:Pons / Q000473:pathology; D051843:Synucleins; D051844:alpha-Synuclein
chemical_list: D000906:Antibodies; D000911:Antibodies, Monoclonal; D009419:Nerve Tissue Proteins; C497604:SNCA protein, human; D051843:Synucleins; D051844:alpha-Synuclein